Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Pfenex Inc (PFNX)

12.75   -0.01 (-0.08%) 10-01 09:31
Open: 12.74 Pre. Close: 12.76
High: 12.94 Low: 12.74
Volume: 1,610,773 Market Cap: 437M
Pfenex, Inc. is a development and licensing Biotechnology Company, which focuses on leveraging its Pfenex Expression Technology platform for developing and improving protein therapies. The company is headquartered in San Diego, California and currently employs 83 full-time employees. The firm is engaged in the development of biosimilar and therapeutic equivalent products to branded therapeutics and other high-value and difficult-to-manufacture proteins. Its lead product candidate is PF582, a biosimilar candidate to Lucentis (ranibizumab). Its next advanced product candidates are PF530 and PF708. PF530 is a biosimilar candidate to Betaseron (interferon beta-1b). PF708 is being developed as a therapeutically equivalent peptide to Forteo (teriparatide), which is for the treatment of osteoporosis. In addition to its three advanced product candidates, its pipeline includes over four other biosimilar candidates, as well as vaccines and next generation biologic candidates. Its product candidates are enabled by its protein production platform, Pfenex Expression Technology. The company is also developing Px563L, an anthrax vaccine candidate, and Px533 as a prophylactic vaccine candidate against malaria infection.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 12.874 - 12.948 12.948 - 13.014
Low: 12.559 - 12.64 12.64 - 12.713
Close: 12.673 - 12.803 12.803 - 12.921

Technical analysis

as of: 2020-09-30 4:45:14 PM
Stoxline posted a NEUTRAL today, downgraded from higher rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 15.13     One year: 17.67
Support: Support1: 12.67    Support2: 12.50
Resistance: Resistance1: 12.95    Resistance2: 15.13
Pivot: 12.72
Moving Average: MA(5): 12.74     MA(20): 12.71
MA(100): 9.53     MA(250): 9.75
MACD: MACD(12,26): 0.34     Signal(9): 0.45
Stochastic oscillator: %K(14,3): 61.83     %D(3): 49.42
RSI: RSI(14): 66.35
52-week: High: 14.00  Low: 5.26  Change(%): 63.6
Average Vol(K): 3-Month: 70600  10-Days: 87883

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.
PFNX has closed below upper band by 17.8%. Bollinger Bands are 91.2% narrower than normal. The narrow width of the bands suggests low volatility as compared to PFNX's normal range. The bands have been in this narrow range for 20 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Thu, 01 Oct 2020
Ligand (LGND) Completes Acquisition of Pfenex Inc. (PFNX) -

Wed, 30 Sep 2020
Is Pfenex Inc. (PFNX) a Keeper? - The News Heater

Wed, 30 Sep 2020
Pfenex Inc. (NYSE:PFNX) – Analysts’ Revisions Show Sentiment Is Improving - Stocks Register

Wed, 30 Sep 2020
Pfenex Inc. (PFNX) can’t be written off after posting last 3-months Average volume of 666.33K - The InvestChronicle

Wed, 30 Sep 2020
Ligand Announces Expiration of Tender Offer for Shares of Pfenex Inc. - BioSpace

Wed, 30 Sep 2020
Renewed Optimism is Surrounding Pfenex Inc. (AMEX:PFNX) - The Oracle Dispatch

Financial Analysis

Growth n/a
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability n/a
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency n/a
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency n/a
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Outperform Discounted cash flow: Outperform
Return on Assets: Underperform Price to Earnings: Underperform
Return on Equity: Underperform Debt to Equity: Neutral
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  AMEX
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 34
Shares Float (M) 34
% Held by Insiders 0.42
% Held by Institutions 82.43
Shares Short (K) 1,150
Shares Short P. Month (K) 865

Stock Financials

EPS -0.100
EPS Est This Year -2.090
EPS Est Next Year -2.480
Book Value (p.s.) 2.430
Profit Margin -7.03
Operating Margin -7.53
Return on Assets (ttm) -2.5
Return on Equity (ttm) -4.3
Qtrly Rev. Growth -91.3
Gross Profit (p.s.) 1.325
Sales Per Share 1.258
EBITDA (p.s.) -0.041
Qtrly Earnings Growth
Operating Cash Flow (M) -2
Levered Free Cash Flow (M) -1

Stock Valuations

PE Ratio -127.90
PEG Ratio
Price to Book value 5.26
Price to Sales 10.16
Price to Cash Flow -179.01

Stock Dividends

Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2020 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.